Companies / BOC Sciences / Sotigalimab
BOC Sciences

Sotigalimab | BOC Sciences

Sotigalimab is a humanized monoclonal antibody targeting CD40. Sotigalimab has been used in the research of pancreatic adenocarcinoma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.